{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:12:50Z","timestamp":1780499570880,"version":"3.54.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ecco-jccjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.crohns.2014.01.014","type":"journal-article","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T07:30:35Z","timestamp":1391499035000},"page":"890-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Mycophenolate mofetil therapy in the management of inflammatory bowel disease \u2014 A retrospective case series and review"],"prefix":"10.1093","volume":"8","author":[{"given":"Matthew R.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon C.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2014.01.014_bb0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/gut.35.3.360","article-title":"Frequency of glucocorticoid resistance and dependency in Crohn's disease","volume":"35","author":"Munkholm","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2014.01.014_bb0010","article-title":"Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease","volume":"1","author":"Prefontaine","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.crohns.2014.01.014_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000545.pub3","article-title":"Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease","volume":"6","author":"Prefontaine","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.crohns.2014.01.014_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000478.pub3","article-title":"Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis","volume":"9","author":"Timmer","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.crohns.2014.01.014_bb0025","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1365-2036.2011.04599.x","article-title":"Review article: remission rates achievable by current therapies for inflammatory bowel disease","volume":"33","author":"Peyrin-Biroulet","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2014.01.014_bb0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.50.4.485","article-title":"The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30year review","volume":"50","author":"Fraser","year":"2002","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.crohns.2014.01.014_bb0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/TP.0b013e318195a421","article-title":"Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis","volume":"87","author":"Moore","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.crohns.2014.01.014_bb0040","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/S0272-6386(99)70095-8","article-title":"Treatment of acute c-ANCA positive vasculitis with mycophenolate mofetil","volume":"34","author":"Waiser","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.crohns.2014.01.014_bb0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09546630310016826","article-title":"Mycophenolate in dermatology","volume":"14","author":"Liu","year":"2003","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.crohns.2014.01.014_bb0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/ard.62.6.534","article-title":"Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk","volume":"62","author":"Bijl","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.crohns.2014.01.014_bb0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2036.2010.04541.x","article-title":"Review article: the role of non-biological drugs in refractory inflammatory bowel disease","volume":"33","author":"Ng","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"13","key":"10.1016\/j.crohns.2014.01.014_bb0060","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3748\/wjg.15.1594","article-title":"Use of mycophenolate mofetil in inflammatory bowel disease","volume":"15","author":"Tan","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.crohns.2014.01.014_bb0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/gut.44.5.625","article-title":"Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease","volume":"44","author":"Neurath","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2014.01.014_bb0070","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1572-0241.2000.02010.x","article-title":"Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study","volume":"95","author":"Orth","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2014.01.014_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2036.2000.00695.x","article-title":"Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease","volume":"14","author":"Fellermann","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2014.01.014_bb0080","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/ibd.20258","article-title":"Mycophenolate mofetil therapy for refractory inflammatory bowel disease","volume":"13","author":"Palaniappan","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2014.01.014_bb0085","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1365-2036.2011.04825.x","article-title":"Mycophenolate mofetil following intolerance or failure of thiopurine therapy in inflammatory bowel diseases","volume":"34","author":"McDermott","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2014.01.014_bb0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00054725-200002000-00003","article-title":"Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease","volume":"6","author":"Hassard","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2014.01.014_bb0095","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1572-0241.2001.03622.x","article-title":"Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?","volume":"96","author":"Miehsler","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2014.01.014_bb0100","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1111\/j.1572-0241.1998.00606.x","article-title":"Mycophenolate mofetil in patients with Crohn's disease","volume":"93","author":"Fickert","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2014.01.014_bb0105","first-page":"17","article-title":"Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate","volume":"26","author":"Hafraoui","year":"2002","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.crohns.2014.01.014_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00054725-200203000-00004","article-title":"Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease","volume":"8","author":"Skelly","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2014.01.014_bb0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2036.2004.01856.x","article-title":"Mycophenolate mofetil for Crohn's disease: short-term efficacy and long-term outcome","volume":"19","author":"Wenzl","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.crohns.2014.01.014_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200002000-00002","article-title":"A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998","volume":"6","author":"Gasche","year":"2000","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.crohns.2014.01.014_bb0125","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gut.46.5.740a","article-title":"Mycophenolate mofetil for Crohn's disease","volume":"46","author":"Atherton","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2014.01.014_bb0130","series-title":"Crohn's disease: management in adults, children and young people, CG152","author":"National Institute for Health and Care Excellence","year":"2012"},{"key":"10.1016\/j.crohns.2014.01.014_bb0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group","volume":"60","author":"Solinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.crohns.2014.01.014_bb0140","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection","volume":"345","author":"European Mycophenolate Mofetil Cooperative Study Group","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.crohns.2014.01.014_bb0145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2036.2007.03570.x","article-title":"Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease","volume":"27","author":"Lees","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2014.01.014_bb0150","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1046\/j.1365-2036.2000.00872.x","article-title":"The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy","volume":"14","author":"Boulton-Jones","year":"2000","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994614000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994614000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/8\/8\/890\/1421040\/8-8-890.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T03:58:36Z","timestamp":1503460716000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2014.01.014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1873994614000191"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2014.01.014","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycophenolate mofetil therapy in the management of inflammatory bowel disease \u2014 A retrospective case series and review","name":"articletitle","label":"Article Title"},{"value":"Journal of Crohn's and Colitis","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.crohns.2014.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}